Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database - 14/01/19
Abstract |
Background |
Sentinel lymph node biopsy (SLNB) specimens are often obtained from patients for further staging after these patients have undergone melanoma excision. Limited data regarding predictors of SLNB positivity in thin melanoma are available.
Objective |
We sought to evaluate predictors of SLNB positivity in thin melanoma.
Methods |
Patients with cutaneous melanoma with a Breslow thickness ≤1.00 mm who received a SLNB were identified from the National Cancer Database between 2004 and 2014 (n = 9186). Predictors of SLNB positivity were analyzed using logistic regression.
Results |
In a multivariate analysis, patients <60 years of age (P < .001) and Breslow thickness >0.8 mm (P = .03) were at increased risk for positive sentinel lymph node (SLN). Moreover, on multivariate analysis, the presence of dermal mitoses increased the odds of SLN positivity by 95% (odds ratio [OR] 1.95 [95% confidence interval {CI} 1.53-2.5], P < .001), ulceration by 63% (OR 1.63 [95% CI 1.21-2.18], P < .001), and Clark level IV to V by 48% (OR 1.48 [95% CI 1.19-1.85]). Patients without ulceration but with dermal mitoses had 92% (OR 1.92 [95% CI 1.5-2.48], P < .001) increased SLN positivity.
Limitations |
Limited survival data are available.
Conclusions |
Younger age, a Breslow thickness >0.8 mm, the presence of dermal mitoses, ulceration, and Clark level IV to V are positive predictors of positive SLN. While the new American Joint Committee on Cancer system has removed dermal mitotic rate from staging, continued evaluation of dermal mitotic rate could be valuable for guiding surgical decision making about SLNB.
Le texte complet de cet article est disponible en PDF.Key words : Clark level, melanoma, mitotic rate, National Cancer Database, sentinel lymph node biopsy, thin
Abbreviations used : AJCC, CI, NCCN, NCDB, OR, SLN, SLNB
Plan
| Funding sources: None. |
|
| Conflicts of interest: None disclosed. |
Vol 80 - N° 2
P. 441-447 - février 2019 Retour au numéro
Article précédent
- Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study
- Andrew N. Hanna, Andrew J. Sinnamon, Robert E. Roses, Rachel R. Kelz, David E. Elder, Xiaowei Xu, Barbara A. Pockaj, Jonathan S. Zager, Douglas L. Fraker, Giorgos C. Karakousis
- Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study
- Feras M. Ghazawi, Janelle Cyr, Rami Darwich, Michelle Le, Elham Rahme, Linda Moreau, Elena Netchiporouk, Andrei Zubarev, Osama Roshdy, Steven J. Glassman, Denis Sasseville, Ivan V. Litvinov
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?